Onyx Biotec Limited (NSE:ONYX)

India flag India · Delayed Price · Currency is INR
45.25
-0.50 (-1.09%)
At close: Sep 19, 2025
-1.09%
Market Cap830.45M
Revenue (ttm)631.19M
Net Income (ttm)49.54M
Shares Out18.13M
EPS (ttm)3.30
PE Ratio13.88
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,000
Average Volume34,300
Open44.55
Previous Close45.75
Day's Range44.55 - 45.50
52-Week Range44.55 - 97.45
Betan/a
RSI39.83
Earnings DateAug 1, 2025

About Onyx Biotec

Onyx Biotec Limited develops, manufactures, and distributes generic pharmaceutical products in India and internationally. The company offers sterile water for injections; and acts as a pharmaceutical contract manufacturer for a range of dry powder injections and dry powder syrups cephalosporins. It also exports its products. The company was incorporated in 2005 and is based in Chandigarh, India. [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol ONYX
Full Company Profile

Financial Performance

In 2024, Onyx Biotec's revenue was 631.19 million, an increase of 17.43% compared to the previous year's 537.49 million. Earnings were 49.54 million, an increase of 63.42%.

Financial Statements

News

There is no news available yet.